Navellier & Associates Inc Novavax Inc Transaction History

Navellier & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$121.0 - $257.67 $430,397 - $916,532	-3,557 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$112.98 - $319.93 $31,069 - $87,980	275 Added 8.38%	3,557 $645,000
Q4 2020 Feb 05, 2021	BUY	$78.74 - $139.5 $32,834 - $58,171	417 Added 14.55%	3,282 $366,000
Q3 2020 Nov 09, 2020	BUY	$79.44 - $178.51 $227,595 - $511,431	2,865 New	2,865 $310,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.